NTRS vs OKUR · P/E 18, rev $2.69B vs P/E 72, rev $2.0M
Northern Trust Corporation (NTRS) versus OnKure Therapeutics, Inc. (OKUR) — a side-by-side from cached financials, not a winner call.
Northern Trust Corporation (NTRS) is a asset management company listed on US.
OnKure Therapeutics, Inc. (OKUR) is a biotechnology company listed on US.
Latest reported NTRS revenue for 2026-06-30 was $2.69B. Net income was $1.32B. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
Latest reported OKUR revenue for 2026-06-30 was $2.0M. Net income was -$30.5M. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
NTRS currently screens at market cap $32.02B and trailing P/E 18.1. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
Not investment advice. Open the NTRS and OKUR stock pages for the full models.
Not investment advice.